RB
Robert I Blum
President & CEODirector

Robert I Blum insider trades: Cytokinetics (CYTK) stock buys and sales

President & CEO, Cytokinetics Last trade Nov 2, 2026 278 Form 4 filings
$16.5M
Sold, last 12 months
16 sales
$0
Bought, last 12 months
0 buys
232
Open-market trades
since 2005
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

232 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 2, 2026CYTK↓ Sell$471K
Oct 12, 2026CYTK↓ Sell$472K
Sep 28, 2026CYTK↓ Sell$491K
Sep 15, 2026CYTK↓ Sell$6.8M
Sep 14, 2026CYTK↓ Sell$551K
Aug 31, 2026CYTK↓ Sell$527K
Aug 10, 2026CYTK↓ Sell$576K
Jul 13, 2026CYTK↓ Sell$615K
Jul 1, 2026CYTK↓ Sell$637K
Jun 15, 2026CYTK↓ Sell$528K
May 27, 2026CYTK↓ Sell$579K
May 14, 2026CYTK↓ Sell$584K
Apr 29, 2026CYTK↓ Sell$447K
Apr 1, 2026CYTK↓ Sell$500K
Mar 17, 2026CYTK↓ Sell$2.3M
Mar 9, 2026CYTK↓ Sell$482K
Oct 30, 2025CYTK↓ Sell$314K
Oct 16, 2025CYTK↓ Sell$300K
Oct 1, 2025CYTK↓ Sell$275K
Sep 15, 2025CYTK↓ Sell$249K
Sep 2, 2025CYTK↓ Sell$244K
Aug 15, 2025CYTK↓ Sell$192K
Jul 29, 2025CYTK↓ Sell$182K
Jul 14, 2025CYTK↓ Sell$191K
Jul 1, 2025CYTK↓ Sell$168K
Jun 16, 2025CYTK↓ Sell$169K
Jun 2, 2025CYTK↓ Sell$156K
May 16, 2025CYTK↓ Sell$155K
Apr 29, 2025CYTK↓ Sell$205K
Apr 10, 2025CYTK↓ Sell$184K
Mar 31, 2025CYTK↓ Sell$611K
Mar 17, 2025CYTK↓ Sell$1.1M
Mar 17, 2025CYTK↓ Sell$561K
Mar 6, 2025CYTK↓ Sell$737K
Mar 5, 2025CYTK↓ Sell$1.1M
Mar 3, 2025CYTK↓ Sell$375K
Dec 2, 2024CYTK↓ Sell$254K
Nov 18, 2024CYTK↓ Sell$253K
Nov 1, 2024CYTK↓ Sell$258K
Oct 9, 2024CYTK↓ Sell$278K
Sep 30, 2024CYTK↓ Sell$261K
Sep 16, 2024CYTK↓ Sell$280K
Sep 3, 2024CYTK↓ Sell$285K
Aug 12, 2024CYTK↓ Sell$634K
Jul 30, 2024CYTK↓ Sell$684K
Jul 10, 2024CYTK↓ Sell$624K
Jul 1, 2024CYTK↓ Sell$622K
Jun 17, 2024CYTK↓ Sell$1.2M
Jun 4, 2024CYTK↓ Sell$1.1M
Feb 13, 2024CYTK↓ Sell$961K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CYTK insiders

Open-market trades in the last 12 months

About Robert I Blum's insider trades

Robert I Blum is President & CEO at Cytokinetics (CYTK). Since Nov 8, 2005, Robert has reported 1 open-market purchase worth $78K and 231 sales worth $61.7M on SEC Form 4. In the last 12 months: 16 sales ($16.5M).

Their filings also include option exercises (175 filings), grants and awards (26 filings), shares withheld for taxes (20 filings), gifts (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.